The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

August 22, 2024

Conditions
Heart FailureMitral Valve InsufficiencyCardiomyopathies
Interventions
DEVICE

Mitral valve repair

Trial Locations (16)

10016

NYU Langone Medical Center, New York

10032

Columbia University Medical Center, New York

10467

Montefiore Medical Center, The Bronx

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

17101

Pinnacle Health Cardiovascular Institute, Harrisburg

22908

University of Virginia School of Medicine, Charlottesville

24014

Carilion Medical Center, Roanoke

30322

Emory University, Atlanta

40202

University of Louisville, Louisville

55407

Minneapolis Heart Foundation Institute, Minneapolis

63110

Barnes-Jewish Hospital, St Louis

68526

Nebraska Heart Institute / Nebraska Heart Hospital, Lincoln

77020

Baylor College of Medicine St. Luke's Medical Center, Houston

84109

Intermountain Medical Center, Salt Lake City

98195

University of Washington Medicine, Seattle

Unknown

The Christ Hospital, Cincinnati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ancora Heart, Inc.

INDUSTRY

NCT02806570 - The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study | Biotech Hunter | Biotech Hunter